Chronobiology of Meal Timing: Effects on Vascular and Renal Function
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Natalie Bohmke
- Phone Number: (540) 842-9009
- Email: bohmkenj@vcu.edu
Study Contact Backup
- Name: Danielle Kirkman
- Phone Number: dlkirkman@vcu.edu
- Email: dlkirkman@vcu.edu
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 232398
- Virginia Commonwealth Univesity
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Men and Women aged 18-45 years
- Elevated (SBP 120-129; DBP <80 mmHg) or stage 1 hypertension (SBP 130-139; DBP 80-89 mmHg)
Exclusion Criteria:
- History of chronic disease (CV, lung, cancer, renal, sleep apnea, diabetes, autoimmune)
- Anti-hypertensive medication use
- Currently pregnant or lactating
- Current shift worker
- Travel >3 time zones four weeks before the start of the study or during the study
- Insomnia
- Practiced intermittent fasting in past six months
- Current nicotine use
- Current hormone replacement therapy
- Current melatonin use
- Current use of antioxidants and unwilling to stop taking them for the duration of the study
- Unable to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Morning Meal Challenge
|
A Western-style diet meal which will be individualized for caloric consumption by estimated total daily energy expenditure eaten after 1 hour of waking up in the morning
|
|
Experimental: Late Night Meal Challenge
|
A Western-style diet meal which will be individualized for caloric consumption by estimated total daily energy expenditure eaten within 1 hour of going to bed
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Urinary sodium excretion and markers of kidney injury
Time Frame: 24 hours
|
Day and nocturnal urinary sodium, NGAL and KIM-1
|
24 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
24hr ambulatory blood pressure
Time Frame: 24 Hours
|
Day and nocturnal ambulatory blood pressure
|
24 Hours
|
|
Macrovascular function
Time Frame: At baseline and after each 24hour experimental arm
|
Brachial artery endothelial function assessed by flow mediated dilation
|
At baseline and after each 24hour experimental arm
|
|
Microvascular function
Time Frame: At baseline and after each 24hour experimental arm
|
Skin blood flow response to local heating measured by laser doppler flowmetry
|
At baseline and after each 24hour experimental arm
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Danielle Kirkman, Virginia Commonwealth University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HM20026660
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.